Nab-paclitaxel plus S-1 as first-line followed by S-1 maintenance for advanced pancreatic adenocarcinoma: a single-arm phase II trial

PURPOSE: We conducted a single-arm prospective phase II study to determine the efficacy and safety of the first-line treatment of advanced pancreatic cancer with nab-paclitaxel and S-1 followed by S-1 maintenance therapy. METHODS: Nab-paclitaxel was administered intravenously on days 1 and 8 at 120 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wen, Du, Chunxia, Sun, Yongkun, Yang, Lin, Cui, Chengxu, Jiang, Zhichao, Wang, Chengfeng, Wang, Jinwang, Zhou, Aiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132856/
https://www.ncbi.nlm.nih.gov/pubmed/30054709
http://dx.doi.org/10.1007/s00280-018-3650-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132856/
https://www.ncbi.nlm.nih.gov/pubmed/30054709
http://dx.doi.org/10.1007/s00280-018-3650-4

Ejemplares similares